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Background: Accessory pathway (AP) ablation is not always easy. Our purpose was to assess
the age-related prevalence of AP location, electrophysiological and prognostic data ac-
cording to this location.
Methods: Electrophysiologic study (EPS) was performed in 994 patients for a pre-excitation
syndrome. AP location was determined on a 12 lead ECG during atrial pacing at maximal
preexcitation and confirmed at intracardiac EPS in 494 patients.
Results: AP location was classified as anteroseptal (AS)(96), right lateral (RL)(54), poster-
oseptal (PS)(459), left lateral (LL)(363), nodoventricular (NV)(22).
Patients with ASAP or RLAP were younger than patients with another AP location.
Poorly-tolerated arrhythmias were more frequent in patients with LLAP than in other pa-
tients (0.009 for ASAP, 0.0037 for RLAP, <0.0001 for PSAP).
Maximal rate conducted over AP was significantly slower in patients with ASAP and
RLAP than in other patients. Malignant forms at EPS were more frequent in patients with
LLAP than in patients with ASAP (0.002) or PSAP (0.001).
Similar data were noted when AP location was confirmed at intracardiac EPS. Among
untreated patients, poorly-tolerated arrhythmia occurred in patients with LLAP (3) or PSAP
(6). Failures of ablation were more frequent for AS or RL AP than for LL or PS AP.
Conclusions: AS and RLAP location in pre-excitation syndrome was more frequent in young
patients. Maximal rate conducted over AP was lower than in other locations. Absence of
poorly-tolerated arrhythmias during follow-up and higher risk of ablation failure should be
taken into account for indications of AP ablation in children with few symptoms.
Copyright © 2016, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V.
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Radiofrequency ablation of the accessory pathway (AP) is the
usual treatment of symptomatic ventricular pre-excitation
syndrome (WolffeParkinsoneWhite syndrome) and of
asymptomatic pre-excitation syndrome with signs of malig-
nancy at electrophysiological study [1,2]. Therefore electro-
physiological study (EPS) is recommended to evaluate the pre-
excitation syndrome-related risk [3e6]. It is well-known that
ventricular fibrillation may be the first event of the pre-
excitation syndrome. Ventricular fibrillation was the first
manifestation in 8 of 15 patients (53%) in the study of Tim-
mermans et al. [7], but aborted sudden death was rare and
seen in 2.2% of this population of 690 patients referred for a
WolffeParkinsoneWhite syndrome [7]. The risk was reported
as lower in a personal study [8]; 6 of 645 patients (0.9%) were
resuscitated from a ventricular fibrillation. Fitzsimmons et al.
[9] reported a sudden cardiac death risk of 0.02% per patient
per year. Male gender, young age, sport, septal accessory
pathway (AP), short AP refractory period, atrial fibrillation (AF)
were reported as risk factors of sudden death in pre-excitation
syndrome [2]. Other indications for AP ablation were the
occurrence of spontaneous AV re-entrant tachycardia [10].
But, ablation of atrioventricular AP is not always simple either
associated with a risk of failure mainly in the case of right
lateral location or associated with complications as the risk of
complete AV block in the case of anteroseptal (AS) or para-
hisian location [11,12].
The purpose of the study was to evaluate the prevalence of
AP location according to the age of patient with a pre-
excitation syndrome, the clinical data and the prognosis of
these patients.Material and methods
Population of study
The population included 994 consecutive patients referred to
our center between 1990 and august 2015 for overt pre-
excitation and indication for electrophysiological study (EPS).
Patients underwent examination for various reasons: a)
414 patients (41.6%) had a known history of paroxysmal
reciprocal tachycardia; b) 31 patients (3.1%) presented with a
well-tolerated AF; c) 359 patients (36%) in whom asymptom-
atic pre-excitation was discovered during a systematic
assessment prior to anesthesia, before obtaining a sporting
license, prior to employment in certain at-risk occupations, or
during an ECG in the preventive medicine department or in
presence of congenital heart disease; d) 114 patients (11.5%)
presented with unexplained syncope without documentation
of any arrhythmia event; e) 76 patients (7.6%) presented a
poorly-tolerated tachycardia, defined as a documented life-
threatening hemodynamically non-tolerated arrhythmia,
with collapsus or syncope and requiring emergency treatment
(ventricular fibrillation in 7 patients, rapid and poorly-
tolerated AF conducted over the accessory pathway in 68 pa-
tients rapid and poorly-tolerated reentrant tachycardia in one
patient).The retrospective study of patients' files was approved by
the Commission Nationale Informatique et Libertes (CNIL), in
keeping with French law for single-center usual care obser-
vational studies. Prior to EPS and ablation, informed consent
was obtained for clinical purposes from all patients and in the
case of children, from children and their parents.Protocol
The protocol included systematic non-invasive (24 h Holter
monitoring and exercise testing) and invasive studies.
EPS was performed systematically generally by trans-
esophageal route in asymptomatic patients or patients with
undocumented tachycardia, or by conventional intracardiac
method. Fig. 1 reports the number of patients studied only by
esophageal route (the most frequent), only intracardiac route
or by both routes. Patients were not sedated. Details of the EPS
protocol have been previously described [5,8].
Briefly, incremental atrial pacing was performed until the
highest rate conducted 1/1 through the AP and/or atrioven-
tricular node. Programmed atrial stimulation at a basic cycle
length of 600 and 400 ms with the respective introduction of
one and two extra-stimuli was performed. For the measure-
ment of the AP effective refractory period (AP ERP), one atrial
extra-stimulus was delivered after 7 paced atrial stimuli at a
cycle length of 400 ms from 390 ms until the AP refractory
pathway or the atrial effective refractory period with 10-msec
decrements. The disappearance of the pre-excitation pattern
was indicated upon reaching the AP ERP. When a fast AF
conducted over AP was induced with this method, the proto-
col was halted; in the absence of induction of tachycardia
conducted over AP at a rate higher than 240 bpm, isoproter-
enol (0.02e1 mg min1) was infused to increase sinus rate to at
least 130 bpm after which the pacing protocol was repeated.
Pre-excitation was characterized by the following data:
AP location was determined with the 12-lead ECG recorded
in maximal pre-excitation according to classical data [13e24].
The location was performed by only one Electrophysiologist.
The location is easy and reliable for left AP and right or left
posteroseptal location. It is more difficult to differentiate with
certainty a right lateral or a parahisian AP (errors in 25% of
cases). Nodo-ventricular AP is diagnosed by the absence of
modification of preexcited QRS and a progressive increase of
AV interval when premature extrastimuli are used.
The exact location of AP was determined by intracardiac
route by the determination of the site where atrioventricular
conduction was the shortest in bipolar and unipolar recording
in 494 patients. Other mapping criteria used for the location
were the earliest ventricular activation, the recording of AP
potential, and the successful ablation site when decision of
ablation was made. The presence of a His bundle potential
near this site in a patient without criteria of malignancy were
contraindications of ablation for our group in the past (before
2010).
Sustained AF or reciprocating tachycardia was defined as a
tachycardia lasting longer than 1 min.
Conduction over the APwas evaluated by themaximal rate
conducted over AP either in tachycardia or during atrial
pacing.
994 patients with PS
Total AP location       Eso EPS alone      Eso and then endo      Endo only      Total endo
AS AP   96                   78                              34                          14     48
RL AP   54                   31                               16                           7                   23
PS AP   459                  251                              117                          91        208
LL AP   363                 158                              102                         103                   205
NV AP   22                     12                                 6                              4           10
Fig. 1 e Representation of the whole population and the method of evaluation. Eso EPS: esophageal electrophysiological
study, Endo: intracardiac electrophysiological study, AP: accessory pathway, AS: anteroseptal, RL: right lateral, PS:
posteroseptal, LL: left lateral, NV: nodo-ventricular.
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at risk of sudden death when the following association was
observed: the shortest RR interval between pre-excited beats
was less than 250 ms in the control state or less or equal to
200 ms after isoproterenol infusion during induced sustained
AF. EPS was considered as negative if no tachycardia was
induced and a long refractory period of accessory pathway
(250ms in control state and >200ms after isoproterenol) was
noted [5,8].
When ablation was indicated, ablation was performed by
the same senior operator with different assisting clinical fel-
lows. AP ablation was made with a 7F deflectable catheter
with a 4 mm electrode by searching the site where atrioven-
tricular conduction was the shortest in bipolar and unipolar
recording. Left AP generally was approached by retrograde
catheterism.
After investigations, asymptomatic patients in whom
there were no electrophysiological criteria for malignancy
were not treated and ablation was not indicated. Ablation of
AP was proposed in symptomatic patients or asymptomatic
patients with detection of a potentially malignant form of the
disease. Antiarrhythmic therapy with beta-blocker and/or
flecainide was the preferred mode of treatment in small
children, in patients with an anteroseptal AP and in patients
who refused ablation.
Patients were followed during 5.1 ± 5 years
Patients in whom ablation was performed had a clinical
visit and a standard-ECG systematic onemonth after ablation.
In those who remained symptomatic despite a normal ECG,
24 h Holter monitoring was systematic and generally a
transesophageal electrophysiological study was performed.
In patients in whom ablation was not performed, tele-
phonic interviews with the patient and the medical referent
were performed.Statistical analysis
Data were expressed as means ± standard deviation (SD) or
proportions, as appropriate. Categorical variables were
compared using the Chi-square test and continuous variables
with the unpaired t test.
Univariable logistic regression was used with the
following dependent variables, age, gender, AP location, his-
tory of poorly-tolerated tachycardia and hemodynamically
poorly-tolerated tachycardia occurrence during follow-up,
malignant form at electrophysiological study. Variables
associated with the considered outcome with a p value <0.10
in univariable analysis were entered in the multivariable
models.
A p-value <0.05 was considered statistically significant. All
statistical analyses were performed using the SPSS package
for Windows (version 20, SPSS Inc, Chicago, Illinois).Results
1 General data on the location of AP in total population:
AS AP location was identified in 94 patients aged 6e57
years. Right lateral (RL) AP was noted in 51 patients. Remain-
ing patients had a different location, right or left posteroseptal
(PS) location in 459 patients, left lateral (LL) location in 359
patients and or nodo-ventricular (NV) AP in 22 patients.
In 8 patients, 2 locations were identified; one of them had
right PS location associated with AS AP. This patient was
classified with AS locations. Three patients had associated PS
AP and right lateral AP; they were classified with right lateral
location. Three patients had a LL and PS AP and another pa-
tient had a LL AP and a NV AP; they were classified as LL
i n d i a n p a c i n g and e l e c t r o p h y s i o l o g y j o u rn a l 1 5 ( 2 0 1 5 ) 2 2 7e2 3 5230location. In 2 patients only studied by esophageal route the
differentiation of AS and RL was not possible and patients
were classified with AS location.
Therefore, 96 patients were classified as having AS AP
location, 54 as having RL AP location, 459 as having PS AP
location, 363 ashaving LLAP locationand 22 ashaving aNVAP.
2 Clinical data according to AP location (Table 1):
Patients with AS AP or RL AP were younger than patients
with another AP location (25 ± 13, 25.5 ± 14 vs 33.2 ± 17.5 for PS
AP, p < 0.001, 36.6 ± 16.7 for LLAP, p < 0.0001).
The incidence by range of age was significantly higher
among patients with NV, AS and RL AP location before 20
years than after 19 years compared to patients with PS and LL
AP location. The statistical differences for AS APwere 0.006 for
PS AP and <0.0001 for LL AP. The statistical differences for RL
AP were 0.03 for PS AP and <0.00001 for LL AP. The differences
continuously increased with age (Table 2). After 59 years AS
AP, RL AP or NV AP were exceptional.
Male gender was significantly more frequent in patients
with RL AP (76.5%) (p 0.03) than in all other locations.
The indications for EPS differed according AP location but
only for LL AP and NV AP location; patients with LL or NV AP
were less frequently asymptomatic than patients with
another AP location: the differenceswere highly significant for
LL AP (0.0006 compared to AS AP, <0.0001 for RL AP and
<0.0001 for PS AP). They were not different for NV AP because
the group was too small. Poorly-tolerated arrhythmias were
more frequent in patients with LL AP than in patients with
another location (p 0.009 for AS AP, 0.0037 for RL AP and
<0.0001 for PS AP). Patients with RL AP have less frequently
spontaneous reentrant tachycardia than patients with LL AP
(p 0.004).
3 Electrophysiological data according to AP location (Table 1):Table 1 e Clinical and electrophysiological data of whole popu
effective refractory period. See Table 1 for remaining abbrevia
excited beats <250 ms in the control state or <200 ms after iso
electrophysiology study. Bold numbers are results which diffe
AS AP RL AP
Number 96 (9.65%) 54 (5.4%)
Age (years) 25 ± 14 25.5 ± 14
Male gender 56 (58%) 39(76.5%)
HD 10 (10.4%) 4 (7.4%)
Asymptomatic 39 (40.6%) 30 (55.5%)
Syncope 10 (10.4%) 3 (5.5%)
Sp AVRT 42 (43.75%) 16 (29.6%)
Sp AF 1 (0.1%) 3 (5.5%)
Sp malignant form 4 (4.2%) 2 (3.7%)
Max HR CS bpm 167.5 ± 58.3 176.5 ± 66
Max HR iso bpm 212.9 ± 69.9 210.8 ± 72.4
AP ERP CS ms 304.7 ± 67 310 ± 87
AP ERP iso ms 243.7 ± 42 248 ± 57.4
Induced AVRT 48 (50%) 24 (47%)
Induced AF 16 (17%) 15 (30%)
Malignant form (EPS) 5 (5.2%) 6 (12%)
Ablation 48 (50%) 23 (42.6%)
Successful ablation 23 (48%) 15 (65%)Maximal rate conducted over AP was significantly slower
in basal state in patients with AS AP than in patients with
another AP location, except with RL AP location. Statistical
data for AS AP were 0.002 compared to PS location, <0.001
compared to LL AP and 0.04 between RL AP and LL AP. After
isoproterenol, maximal rate conducted over AP was signifi-
cantly slower for AS and RL AP compared to PS and LL AP (0.03
for PS AP compared to AS AP, 0.044 for PS AP compared to RL
AP; <0.0002 for LL AP compared to AS AP, 0.02 for LL AP
compared to RL AP).
Atrio-ventricular reentrant tachycardia (AVRT) was more
frequently induced in patients with LL AP (67%) than in pa-
tients with all other AP locations (0.002 compared to RL AP,
0.004 compared to AS AP, <0.0001 compared to PS AP).
The induction of AF was less frequent in patients with AS
AP and PS AP than in patients with LL AP (0.005 between AS AP
and LL AP, 0.0001 between PS AP and LL AP).
The number of potentially malignant forms at EPS was
more frequent in patients with LL AP than in patients with AS
AP (0.002) or patients with PS AP (0.001) and differences were
not significant with patients with RL AP.
4 Data of patients in whom intracardiac electrophysiological
study was performed in view of AP ablation (Table 3):
Intracardiac study was indicated in 494 of 994 patients
(49.7%) with a pre-excitation syndrome for spontaneous
paroxysmal reciprocal tachycardia in 277 patients (56%), for
well-tolerated AF in 19 patients (3.9%), for pathological
esophageal study in 84 asymptomatic patients (induced AVRT
in 30 patients, induced in AF with a rapid conduction over AP
44 patients, short AP ERP in 10 athletes); 35 patients (8.3%) had
pre-excitation syndrome-related syncope at esophageal study
(induced AVRT 30, induced antidromic tachycardia 1, induced
AF with a rapid conduction over AP 4); 65 patients (13.2%) had
a spontaneous poorly-tolerated tachycardia; in 13 patients thelation according to the AP location. Sp: spontaneous; ERP,
tions. Malignant form: shortest RR interval between pre-
proterenol infusion during induced sustained AF; EPS:
r significantly (details in the manuscript).
PS AP LL AP NV AP
459 (46.2%) 363 (36.5%) 22 (0.2%)
33.2 ± 17.5 36.6 ± 16.7 32.4 ± 18
287 (62.5%) 218 (60%) 13 (59%)
34 (7.4%) 25 (6.9%) 5 (22.7%)
201 (43.8%) 84 (23.1%) 5 (22.7%)
67 (14.6%) 31 (8.5%) 3 (13.6%)
160 (34.8%) 182 (50%) 14 (64%)
11 (2.4%) 16 (4.4%) 0
20 (4.3%) 50 (13.8%) 0
189 ± 63 202 ± 67.4 152 ± 40
231 ± 66.5 247 ± 69.3 189 ± 50
290.3 ± 74.5 275.1 ± 72
234 ± 56.5 220.6 ± 39.7
211 (46%) 240 (66%) 10(45.4%)
89 (19.4%) 113 (31%) 4 (18%)
44 (9.6%) 63 (17.4%) 0
208 (57%) 205 (56.5%) 10 (45%)
175 (84%) 184 (90%) 6 (60%)
Table 2 e Prevalence of AP location according to the age of the patient.
AS AP RL AP PS AP LL AP NV AP
6e19 years 283 46 (16.2%) 24 (8.5%) 137 (18.4%) 67 (23.7%) 9 (3.1%)
>19 years 711 50 (7%) 30 (4.2%) 322 (45.3%) 296 (41.6%) 13 (41.6%)
6e19 years 283 46 (16.2%) 24 (8.5%) 137 (18.4%) 67 (23.7%) 9 (3.1%)
20e29 years 215 22 (10.2%) 10 (4.6%) 84 (39%) 67 (31.2%) 2 (1%)
30e39 years 172 11 (6.4%) 11 (6.4%) 78 (45.3%) 69 (40.1%) 3 (1.7%)
40e49 years 159 10 (6.3%) 5 (3.1%) 64 (40.2%) 75 (47.1%) 5 (3.1%)
50e59 years 122 6 (4.9%) 4 (3.2%) 58 (47.5%) 52 (42.6%) 2 (1%)
60e89 years 73 1 (1.4%) 0 38 (52%) 33(45.2%) 1 (1.4%)
Table 3 e Clinical and electrophysiological data of patients in whom AP location was confirmed by intracardiac study. The
Bold numbers are those where results differ significantly (details in the manuscript).
AS AP RL AP PS AP LL AP NV AP
Number 48 23 208 205 10
Age (years) 25 ± 13 25 ± 12 33 ± 17 36.5 ± 16 39 ± 18
Male gender 29 (60.4%) 20 (87%) 124 (60%) 125 (61%) 6 (60%)
HD 5 (10.4%) 2 (9%) 16 (8%) 18 (9%) 2 (20%)
Asymptomatic 6 (12.5%) 7 (30%) 47 (22.5%) 27 (13%) 1 (10%)
Syncope 6 (2.5%) 2 (9%) 23 (11%) 13 (6%) 1 (10%)
Sp AVRT 32 (67%) 9 (39%) 118 (57%) 110 (54%) 8 (80%)
Sp AF 0 3 (13%) 5 (2.4%) 11 (5%) 0
Sp malignant form 4 (8%) 2 (9%) 1 (7%) 44 (21.5%) 0
Max HR CS bpm 172 ± 60.5 189.5 ± 81 207 ± 68 214.5 ± 168 32 ± 56
Max HR iso bpm 222 ± 74 197 ± 89 251 ± 64.5 259 ± 69 132 ± 56
AP ERP CS ms 308 ± 58 306 ± 96 268 ± 58.5 272 ± 73
AP ERP iso ms 241 ± 47 267 ± 84 218 ± 52 217 ± 45
Induced AVRT 41 (85%) 16 (69.5%) 140 (67%) 157 (77%) 8 (80%)
Induced AF 14 (29%) 12 (52%) 57 (27%) 83 (40.5%) 1 (10%)
Malignant form (EPS) 5 (10.4%) 6 (26%) 32 (15%) 54 (26.5%)
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route at the demand of the patient. The details of patients
studied by intracardiac study are detailed in Fig. 1.
Patients with AS AP or RL AP were still younger than pa-
tients with another AP location (25 ± 13, 25 ± 12 vs 33 ± 17 for
PS AP, p < 0.002, 36.5 ± 16, for LL AP p < 0.0001).
Male gender was significantly more frequent in patients
with RLAP than in all other locations (87%) (p 0.01 for LL and PS
location, 0.02 for AS AP) Fig. 2.0
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Fig. 2 e Prevalence of AP location according to the age of
patient. The legend represents the ranges of age (6e19
years).The indications for EPS did not differ except for sponta-
neous AVRT more frequent in patients with AS AP than in
patients with RL AP and for spontaneous AF more frequent in
patients with RL AP compared to patients with AS AP or PS AP.
Spontaneous malignant form was more frequent in patients
with LL AP than in patients with AS AP (p 0.04) and in patients
with PS AP (<0.0001).
Electrophysiological data according to AP location were
also similar to the data of whole population (Table 3).
The maximal rate conducted over AP was significantly
slower in basal state in patients with AS AP than in patients
with another AP location, except with RL AP location. The
statistical data for AS AP were 0.001 compared to PS location
and 0.0005 compared to LL AP. After isoproterenol maximal
rate conducted over AP was significantly slower for AS and RL
AP compared to PS and LL AP (0.0065 for PS AP compared to AS
AP, 0.0065 for PS AP compared to RL AP; 0.01 for LL AP
compared to AS AP, 0.004 for LL AP compared to RL AP).
The induction of AVRT was more frequent in patients with
LL AP (67%) than with all other AP locations that did not differ
for this induction (p < 0.0001 for RL AP, 0.023 for AS AP, <0.0001
for PS AP).
The induction of AF was less frequent in patients with PS
AP than in patients with RL AP (0.013) and in patients with LL
AP (0.005).
The number of potentially malignant forms at EPS was
more frequent in patients with LL AP than in patients with AS
AP (p 0.02) and patients with PS AP (0.006).
Table 4 e Multivariate analysis of the factors associated
with spontaneous poorly-tolerated arrhythmia and
factors associated with the presence of signs of
malignancy at electrophysiological study. Sp AE:
spontaneous adverse event (poorly-tolerated
arrhythmia).
Sp AE p OR CI 95.0% CI 95%
Inferior Superior
Age 0.000 1.026 1.013 1.040
Gender (male) 0.11 0.668 0.407 1.097
Heart disease 0.22 0.549 0.211 1.432
LL AP 0.000 3.001 1.861 4.861
PS AP 0.001 0.443 0.268 0.730
AS AP 0.363 0.616 0.217 1.748
RL AP 0.346 0.500 0.118 2.2116
Malignancy at EPS p OR CI 95.0% CI 95%
Inferior Superior
Age 0.1 0.988 0.975 1.002
Gender (male) 0.451 0.451 0.521 1.336
Sp adverse event 0.000 28.249 16.000 49.874
Heart disease 0.089 0.367 0.115 1.167
LL AP 0.045 1.601 1.011 2.535
PS AP 0.502 0.854 0.540 1.352
AS AP 0.070 0.381 0.134 1.084
RL AP 0.762 1.161 0.443 3.040
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Patients were followed from 2 months to 20 years (mean
5.1 ± 5 years).
Ablation was indicated as frequently in patients with AS,
RL, PS and LL AP. However the success of ablation was
significantly higher in patients with LL AP compared to AS AP
(<0.0001) or RL AP (0.008) and in patients with PS AP compared
to patients with AS AP (<0.0001) or RL AP (0.02): ablation was
successful in 403 patients. In 12 patients ablation was not
performed because His potential recording was very near of
AP in 11 patients with AS AP and in one patient with a RL AP
because conduction over AP was poor and tachycardia was
not induced. Reappearance of AP was noted in 35 patients (14
patients with LL AP (7%), 11 with PS AP (5.3%), 3 with a RL AP
(13%) (NS) and 7 with AS AP (14.5%) (0.02 compared to LL AP
and PS AP)). Ablation failed in 43 patients (7 with LL AP (3.4%),
22 with PS AP (10.5%), 6 with AS AP (12.5%) (0.01 compared to
LL AP), 4 with RL AP (17%). One complete AV occurred in a
patient with AS AP but this patient was seen at the beginning
of the ablation technique.
Among the 591 patients with failure of ablation (n ¼ 91) or
not treated by AP ablation (n ¼ 500) a spontaneous poorly-
tolerated arrhythmia occurred in 9 patients: 3 patients with
a LL AP developed this event; one patient only had initially
reentrant tachycardia, one patientwas asymptomatic and one
had initially a well-tolerated AF. Six patients with a PS AP
developed a spontaneous poorly-tolerated arrhythmia; 4 had
initially reentrant tachycardia and 2 were asymptomatic.
None patient with AS or RL AP developed adverse event after
initial evaluation.
A second EPS was performed in 123 patients between 6 and
9 years later (mean 7.9 ± 4). The reasons were various: in 10
patients initially studied for unexplained syncope, 2 had still
syncope, 4 had symptoms of tachycardia, 3 were asymptom-
atic and one presented AF. In 62 patients with initially reen-
trant tachycardia, 9 were asymptomatic, 3 had syncope, 3 had
AF, 2 had a spontaneous malignant form and 45 had still
symptoms of tachycardia. In 42 initially asymptomatic pa-
tients, 5 had syncope, 2 had AF, 2 had a spontaneous malig-
nant form, 10 had symptoms of tachycardia and 23 patients
remained asymptomatic. AP has lost the anterograde con-
duction properties in 9 of 40 patients with a LL AP (22.5%), 10 of
49 patients with a PS AP (20.4%), 8 of 20 patients with AS AP
(40%) and 6 of 13 patients with RL AP (46%). The differences
were not significant.
6 Multivariate analysis:
Age, LL AP location and PS AP location were independent
factors of the occurrence of a spontaneous poorly-tolerated
arrhythmia (Table 4). Spontaneous poorly-tolerated
arrhythmia and LL AP location were independent factors to
findsignsofmalignancyat electrophysiological study (Table4).Discussion
Patients with AS AP or RL AP are younger than patients with
another AP location. They had a slower maximal heart rateconducted over AP than patients with another AP location.
Spontaneous malignant form and malignant form identified
by electrophysiological study were more frequent in patients
with LL AP than in patients with another AP location. During
the follow-up in untreated patients, spontaneous poorly-
tolerated arrhythmia only occurred in patients with LL or PS
AP. Failure of ablation was less frequent in patients with LL or
PS AP. Therefore in the case of difficult or failed AP ablation of
young patients with AS or RL AP, it is recommended to wait a
spontaneous disappearance of AP except in patients with
signs of malignancy. Data on patients with NV AP were not
analyzed because these patients were too rare to obtain sig-
nificant differences. As previously known, their prognosis was
excellent.
We could provide hypothesis, even if speculative, for these
results and these different features of APs according to their
location. Left-sided APs have higher rates of induced AF
because of their higher conduction rates; but older age of
these patients could be the cause of favoring AF vulnerability
with consequently that left APs represent more malignant
substrates?
Several studies reported the data of electrocardiographic
characteristics according to their localization [13e18]. Hagh-
joo [17] compared the data of 120 patients with AS, midseptal
and PS AP and reported thatmidseptal APswere characterized
by faster orthodromic tachycardia, whereas posteroseptal APs
had a higher inducibility of atrial fibrillation.
Several data differ from previously reported data probably
because the old group studies were of small number.
For example, Arya [19] reported that conduction properties
of accessory pathways (APs) are independent of location and
conduction mode (except in patients with multiple, Mahaim,
and slowly conducting APs). Patients with right-sided APs
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arrhythmia cycle length due to slower anterograde conduc-
tion over the atrioventricular node during atrioventricular
reentrant tachycardia.
Some of our data were similar to data of de Chillou and al
[20] in 1992. The authors reported that location of the acces-
sory AV pathway was associated with specific electrophysio-
logic characteristics. As in our study later age at onset of
symptoms in the left free wall versus other AP locations and
later age at the time of EPS in the left free wall AP location
were reported. Other data differ. Orthodromic reentrant
tachycardia was induced less frequently in the right free wall
than in other locations and inducibility of AF was greater in
anteroseptal (62%) than in right free wall (21%), left free wall
(44%) and posteroseptal (36%) locations (p ¼ 0.01). In the pre-
sent study induction of AVRT was only more frequent in pa-
tients with LL AP than in other AP locations and AF was rarely
induced in patients with AS AP (17%).
In a small group of 45 patients, Kentsch [21] reported that
antegrade effective refractory periods of septally located
accessory pathways were significantly longer than of path-
ways located in the free wall of the ventricles. Luria [22] in a
small group of 24 patients with inducible antidromic tachy-
cardia reported a significantly longer anterograde conduction
time through the AP and retrograde atrioventricular nodal
conduction time in patients with paraseptal versus lateral
pathways.
In the literature, complications of RF AP ablations were not
rare and mainly reported for AS location [23e30] despite a
trend for an actual lower risk [31e34]. In the study of Shaffer
[12] in children, inadvertent atrioventricular block was related
to the ablation anatomic site: (2.7%) anteroseptal, (10.4%)
midseptal, and (1.0%) right posteroseptal sites (P ¼ 0.0007 for
anteroseptal, P ¼ 0.0001 for midseptal, and P ¼ 0.17 for right
posteroseptal versus left septal sites). Moreover, in the present
study, the prevalence of unsuccessful ablation was higher in
patients with AS AP or RL AP without real negative prognosis
value for the follow-up.
Even there was no statistical difference, butmore than 20%
(from 20 to 45%) of these patients demonstrated loss of ante-
grade AP conduction with time and this data should be noted
in patients with ablation at risk of complications or in patients
with few symptoms refusing ablation.
Limitations of study.
They are many.
Only 494 of 994 patients had the confirmation of exact AP
location by intracardiac study. As noted previously ECG in
maximal pre-excitation cannot always differentiate ante-
roseptal and right lateral AP (errors in 25% of cases). However,
clinical and electrophysiological data of these 2 locationswere
similar (younger age and slower anterograde conduction over
AP). The discrepancies only concerned spontaneous symp-
toms of the whole population studied for a pre-excitation
syndrome compared to data obtained at the time of ablation.
They are explained by the fact that asymptomatic patients
frequently did not require invasive studies. Esophageal EPS is
sufficient to evaluate the prognosis of patients with a pre-
excitation syndrome [35]. Patients who require ablation are
more symptomatic or have more induced arrhythmias or
malignant forms. The data are confirmed in the present study.Only 4 main locations were studied. More precise locations
could have been used. Katsouras (18) report the ECG data of
AP's located at left atrioventricular ring, right atrioventricular
ring, left lateral/left anterolateral, left posterior/left postero-
lateral, left posteroseptal, right midseptal, right posteroseptal,
right posterior/right posterolateral, right lateral/right antero-
lateral and right anterior/right anteroseptal. The author did
not find specific criteria for the many locations frequently
often close to each other. For example the successful ablation
of a PS AP may require applications of radiofrequency energy
at right and left posteroseptal site.
We have excluded from statistical analysis the patients
with nodo-ventricular AP. The EP features of this AP are
compatiblewith fasciculo-ventricular APswhich are known to
have a bystander/innocent role and do not require ablation.
Nodo-ventricular APs might be associated with pre-excitation
change depending on their take-off level from the AV node,
and they may also participate in reentrant tachycardias
requiring ablation.
The rationale for the classification of 10 patients with
multiple or unknown location and the exclusion of statistical
analysis is debatable.
This study is retrospective including single center data.
Caution should be taken when analyzing other cohorts of
patients with different races, demographical and genetic
characteristics.
Other limitation is that a part of patients were included in
the very early era of catheter ablation (since 1990). This may
have contributed to less favorable outcomes of catheter
ablation.Conclusions
AS and RL AP location in pre-excitation syndrome was more
frequent in young patients. Maximal rate conducted over AP
was lower than in other locations. Absence of poorly-tolerated
arrhythmias during follow-up and higher risk of ablation
failure in these young patients should be taken into account
for preventive indications of AP ablation or in children with
few symptoms.Disclosure
No disclosures.
Abbreviations
AP accessory pathway
AF atrial fibrillation
AS anteroseptal
AVRT atrioventricular reentrant tachycardia
EPS electrophysiological study
ERP effective refractory period
LL left lateral
NV nodo-ventricular
PS posteroseptal
RL right lateral
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